We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts: FDA Biosimilars Guidance Could Still Be Years Away
Experts: FDA Biosimilars Guidance Could Still Be Years Away
October 26, 2010
As drugmakers continue to wait for the FDA to develop an approval pathway for biosimilars, industry experts are beginning to think that any guidance from the agency could still be years away.